Abstract
Lymph forms from the fluid that is forced out of capillaries and postcapillary venules by hydrostatic pressures, into the interstitium around the vessel. This protein-rich fluid flows through the extracellular matrix and between cells bathing them in nutrients and oxygen and carrying away cellular metabolites and waste products where it is collected by lymphatic capillaries and on to lymph nodes. As with the physiological situation, interstitial fluid and lymph also form within and around tumors, which are collected from cancer-associated tissues. What does change in this situation, however, is the surroundings in which lymph is generated and the tissues exposed to the resulting fluid. The environment in which lymph is formed and transported via can modify its composition and have drastic effects on cells and tissues downstream. This chapter explores the roles of lymphatic function, lymph transport, and their far-reaching implications in cancer development and progression. We pay particular attention to the mechanisms of lymph formation and composition, lymph clearance and resulting cellular effects, the impact on potential antitumour immune responses, methods to identify and measure lymphatic function, and new approaches to exploit or target lymphatics for therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abengozar MA et al (2012) Blocking ephrin-B2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. Blood 119:4565–4576
Batchelor TT et al (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11:83–95
Batchelor TT et al (2010) Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol 28:2817–2823
Berk DA, Swartz MA, Leu AJ, Jain RK (1996) Transport in lymphatic capillaries. II. Microscopic velocity measurement with fluorescence photobleaching. Am J Physiol 270:H330–H337
Boucher Y, Baxter LT, Jain RK (1990) Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50:4478–4484
Butler TP, Gullino PM (1975) Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35:512–516
Byers SW, Sommers CL, Hoxter B, Mercurio AM, Tozeren A (1995) Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell-cell adhesion strength. J Cell Sci 108(Pt 5):2053–2064
Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10:417–427
Celis JE et al (2004) Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics 3:327–344
Celis JE et al (2005) Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics 4:492–522
Chary SR, Jain RK (1989) Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci USA 86:5385–5389
Choi I et al (2011) Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood 117:362–365
Clement CC et al (2010) An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma. PLoS One 5:e9863
Clement CC, Rotzschke O, Santambrogio L (2011) The lymph as a pool of self-antigens. Trends Immunol 32:6–11
Cohen JN et al (2010) Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med 207:681–688
Cohen SM, Fishinghawk BG, Cohen MS (2011) Translational imaging of lymphatics in cancer. Adv Drug Deliv Rev 63:956–962
Condeelis J, Segall JE (2003) Intravital imaging of cell movement in tumours. Nat Rev Cancer 3:921–930
Dafni H, Israely T, Bhujwalla ZM, Benjamin LE, Neeman M (2002) Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. Cancer Res 62:6731–6739
de Rezende LF, Pedras FV, Ramos CD, Gurgel MS (2011) Evaluation of lymphatic compensation by lymphoscintigraphy in the postoperative period of breast cancer surgery with axillary dissection. Tumori 97:309–315
Emmett MS et al (2010) Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density. BMC Cancer 10:208
Emmett MS, Lanati S, Dunn DB, Stone OA, Bates DO (2011) CCR7 mediates directed growth of melanomas towards lymphatics. Microcirculation 18:172–182
Fletcher AL et al (2010) Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J Exp Med 207:689–697
Fleury ME, Boardman KC, Swartz MA (2006) Autologous morphogen gradients by subtle interstitial flow and matrix interactions. Biophys J 91:113–121
Gaggioli C et al (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 9:1392–1400
Gallego E et al (2011) Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas. Virchows Arch 458:621–630
Grepin R et al (2012) Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines. Oncogene 31:1683–1694
Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S (2000) Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 192:1425–1440
Gullino PM, Clark SH, Grantham FH (1964) The interstitial fluid of solid tumors. Cancer Res 24:780–794
Gutmann R et al (1992) Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res 52:1993–1995
Haessler U, Teo JC, Foretay D, Renaud P, Swartz MA (2012) Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Integr Biol (Camb) 4:401–409
Hagendoorn J et al (2006) Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res 66:3360–3364
Hagerling R, Pollmann C, Kremer L, Andresen V, Kiefer F (2011) Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse. Biochem Soc Trans 39:1674–1681
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Harrell M, Iritani B, Ruddell A (2007) Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170:774–786
Hashizume H et al (2000) Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156:1363–1380
Haslene-Hox H et al (2011) A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue. PLoS One 6:e19217
Heldin CH, Rubin K, Pietras K, Ostman A (2004) High interstitial fluid pressure—an obstacle in cancer therapy. Nat Rev Cancer 4:806–813
Helm CL, Fleury ME, Zisch AH, Boschetti F, Swartz MA (2005) Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc Natl Acad Sci USA 102:15779–15784
Hirakawa S et al (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089–1099
Hirakawa S et al (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010–1017
Hofmann M et al (2006) Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model. Neoplasia 8:89–95
Holopainen T et al (2012) Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J Natl Cancer Inst 104:461–475
Hoshida T et al (2006) Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66:8065–8075
Hwang-Bo J, Hyun Yoo K, Park JH, Jeong HS, Chung IS (2012) Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis. Int J Cancer 131:298–309
Isaka N, Padera TP, Hagendoorn J, Fukumura D, Jain RK (2004) Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res 64:4400–4404
Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA (2009) Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res 69:349–357
Jain RK, Fenton BT (2002) Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J Natl Cancer Inst 94:417–421
Jakob C et al (2011) Lymphangiogenesis in regional lymph nodes is an independent prognostic marker in rectal cancer patients after neoadjuvant treatment. PLoS One 6:e27402
Jeon BH et al (2008) Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. Cancer Res 68:1100–1109
Juarranz A, Jaen P, Sanz-Rodriguez F, Cuevas J, Gonzalez S (2008) Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 10:148–154
Karlsen TV, McCormack E, Mujic M, Tenstad O, Wiig H (2012) Minimally invasive quantification of lymph flow in mice and rats by imaging depot clearance of near-infrared albumin. Am J Physiol Heart Circ Physiol 302:H391–H401
Karnezis T et al (2012) VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 21:181–195
Kodera Y et al (2011) Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3. Breast Cancer Res 13:R66
Kurahara H et al (2010) Significance of lymphangiogenesis in primary tumor and draining lymph nodes during lymphatic metastasis of pancreatic head cancer. J Surg Oncol 102:809–815
Kwon S, Sevick-Muraca EM (2007) Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol 5:219–231
Lai G, Rockall AG (2010) Lymph node imaging in gynecologic malignancy. Semin Ultrasound CT MR 31:363–376
Leak LV et al (2004) Proteomic analysis of lymph. Proteomics 4:753–765
Lee JW et al (2007) Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol 8:181–190
Leu AJ, Berk DA, Yuan F, Jain RK (1994a) Flow velocity in the superficial lymphatic network of the mouse tail. Am J Physiol 267:H1507–H1513
Leu AJ et al (1994b) Microvascular dynamics in normal skin versus skin overlying Kaposi’s sarcoma. Microvasc Res 47:140–144
Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324–4327
Liao S et al (2011) Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci USA 108:18784–18789
Liotta LA, Kleinerman J, Saidel GM (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34:997–1004
Liu J et al (2011) PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Clin Cancer Res 17:3638–3648
Lukacs-Kornek V et al (2011) Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat Immunol 12:1096–1104
Lund A, Duares FV, Hirosue S, Raghavan VR, Nembrini C, Thomas SN, Issa A, Hugues S, Swartz MA (2012) VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep 1:191–199
Lunt SJ et al (2008) Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer 8:2
Mandriota SJ et al (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672–682
Mannello F, Medda V, Tonti GA (2009) Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients. Expert Rev Proteomics 6:43–60
Martinez-Corral I et al (2012) In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis. Proc Natl Acad Sci USA 109:6223–6228
Matsui J et al (2008) Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin Cancer Res 14:5459–5465
Mattila MM et al (2002) VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98:946–951
Maus EA et al (2012) Near-infrared fluorescence imaging of lymphatics in head and neck lymphedema. Head Neck 34:448–453
Mazzone M et al (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136:839–851
McDonald DM, Baluk P (2002) Significance of blood vessel leakiness in cancer. Cancer Res 62:5381–5385
Miteva DO et al (2010) Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ Res 106:920–931
Mittal A et al (2009) The proteome of mesenteric lymph during acute pancreatitis and implications for treatment. JOP 10:130–142
Modi S, Stanton AW, Mortimer PS, Levick JR (2007a) Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: a critical review of lymphoscintigraphy. Lymphat Res Biol 5:183–202
Modi S et al (2007b) Human lymphatic pumping measured in healthy and lymphoedematous arms by lymphatic congestion lymphoscintigraphy. J Physiol 583:271–285
Mouli SK, Zhao LC, Omary RA, Thaxton CS (2010) Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors. Nat Rev Urol 7:84–93
Moussai D et al (2011) The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. J Invest Dermatol 131:229–236
Mumprecht V et al (2010) In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography. Cancer Res 70:8842–8851
Nakamura Y et al (2005) Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat 91:125–132
Nathan SS et al (2009) Tumour interstitial fluid pressure may regulate angiogenic factors in osteosarcoma. Ann Acad Med Singapore 38:1041–1047
Ng CP, Swartz MA (2003) Fibroblast alignment under interstitial fluid flow using a novel 3-D tissue culture model. Am J Physiol Heart Circ Physiol 284:H1771–H1777
Ng CP, Swartz MA (2006) Mechanisms of interstitial flow-induced remodeling of fibroblast-collagen cultures. Ann Biomed Eng 34:446–454
Ng CP, Helm CL, Swartz MA (2004) Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc Res 68:258–264
Ng CP, Hinz B, Swartz MA (2005) Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci 118:4731–4739
Niedbala W et al (2007) Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc Natl Acad Sci USA 104:15478–15483
Padera TP et al (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296:1883–1886
Patel DD et al (2001) Chemokines have diverse abilities to form solid phase gradients. Clin Immunol 99:43–52
Patel V et al (2011) Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res 71:7103–7112
Pathak AP et al (2005) Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging. Cancer Res 65:1425–1432
Peinado H, Lavotshkin S, Lyden D (2011) The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol 21:139–146
Polacheck WJ, Charest JL, Kamm RD (2011) Interstitial flow influences direction of tumor cell migration through competing mechanisms. Proc Natl Acad Sci USA 108:11115–11120
Psaila B, Lyden D (2009) The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9:285–293
Rasmussen JC, Tan IC, Marshall MV, Fife CE, Sevick-Muraca EM (2009) Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol 20:74–82
Rinderknecht M, Villa A, Ballmer-Hofer K, Neri D, Detmar M (2010) Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3. PLoS One 5:e11941
Roberts N et al (2006) Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 66:2650–2657
Roozendaal R, Mebius RE, Kraal G (2008) The conduit system of the lymph node. Int Immunol 20:1483–1487
Roozendaal R et al (2009) Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity 30:264–276
Ruddell A et al (2008) Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow. Neoplasia 10:706–713, 701 p following 713
Schomber T et al (2009) Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis. Mol Cancer Ther 8:55–63
Schoppmann SF et al (2006) VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 139:839–846
Sevick-Muraca EM (2012) Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med 63:217–231
Sevick-Muraca EM et al (2008) Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 246:734–741
Shieh AC, Rozansky HA, Hinz B, Swartz MA (2011) Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. Cancer Res 71:790–800
Shields JD et al (2004) Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer 90:693–700
Shields J et al (2007a) Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11:526–538
Shields JD et al (2007b) Chemokine-mediated migration of melanoma cells towards lymphatics—a mechanism contributing to metastasis. Oncogene 26:2997–3005
Shields JD et al (2010) Induction of lymphoid-like stroma and immune escape by tumors that express the chemokine CCL21. Science 328:749–752
Sixt M et al (2005) The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22:19–29
Skobe M et al (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192–198
Stacker SA et al (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186–191
Stanton AW et al (2006) A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment. Clin Sci (Lond) 110:553–561
Stohrer M, Boucher Y, Stangassinger M, Jain RK (2000) Oncotic pressure in solid tumors is elevated. Cancer Res 60:4251–4255
Swartz MA, Berk DA, Jain RK (1996) Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory. Am J Physiol 270:H324–H329
Szuba A, Pyszel A, Jedrzejuk D, Janczak D, Andrzejak R (2007) Presence of functional axillary lymph nodes and lymph drainage within arms in women with and without breast cancer-related lymphedema. Lymphology 40:81–86
Tammela T et al (2011) Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Sci Transl Med 3:69ra11
Teng PN et al (2010) Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis. J Proteome Res 9:4161–4169
Tong RT et al (2004) Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64:3731–3736
Truman LA et al (2012) ProxTom lymphatic vessel reporter mice reveal Prox1 expression in the adrenal medulla, megakaryocytes, and platelets. Am J Pathol 180:1715–1725
Tvorogov D et al (2010) Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell 18:630–640
Vakoc BJ et al (2009) Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat Med 15:1219–1223
Wiig H, Tveit E, Hultborn R, Reed RK, Weiss L (1982) Interstitial fluid pressure in DMBA-induced rat mammary tumours. Scand J Clin Lab Invest 42:159–164
Wiig H, Aukland K, Tenstad O (2003) Isolation of interstitial fluid from rat mammary tumors by a centrifugation method. Am J Physiol Heart Circ Physiol 284:H416–H424
Wiig H, Tenstad O, Iversen PO, Kalluri R, Bjerkvig R (2010) Interstitial fluid: the overlooked component of the tumor microenvironment? Fibrogenesis Tissue Repair 3:12
Willett CG et al (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145–147
Winkler F et al (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6:553–563
Yang H et al (2011) Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Mol Cancer 10:36
Yuan F et al (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 93:14765–14770
Zhao J et al (2010) Towards characteristics of photodynamic drugs specifically aimed at microvascular diseases. Mini Rev Med Chem 10:332–341
Zilberberg L et al (2012) Specificity of latent TGF-β binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin. J Cell Physiol 227:3828–3836
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shields, J. (2013). Lymph and Lymphatic Capillaries in Cancer. In: Santambrogio, L. (eds) Immunology of the Lymphatic System. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3235-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3235-7_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3234-0
Online ISBN: 978-1-4614-3235-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)